Search
for
Sort by
Research 30 of 1000+
- Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin.
- Cell-Type-Specific Chromatin States Differentially Prime Squamous Cell Carcinoma Tumor-Initiating Cells for Epithelial to Mesenchymal Transition
- Independent genomewide screens identify the tumor suppressor VTRNA2-1 as a human epiallele responsive to periconceptional environment
- Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice
- CD34 Expression by Hair Follicle Stem Cells Is Required for Skin Tumor Development in Mice
- Overexpression of protein kinase C-α in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2 and TNF-α expression but not tumor promotion
- Genetic architecture of mouse skin inflammation and tumour susceptibility
- Tumor Angiogenesis and Anti-angiogenic Therapy
- Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion.
- Regulation of Mitochondrial Oxidative Metabolism by Tumor Suppressor FLCN
- Protein kinase Cepsilon is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Cepsilon transgenic mice.
- Induction of dark keratinocytes by 12-O-tetradecanoyl-phorbol-13-acetate and mezerein as an indicator of tumor-promoting efficiency
- Hair Follicle–Derived Blood Vessels Vascularize Tumors in Skin and Are Inhibited by Doxorubicin
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Stem cell quiescence acts as a tumour suppressor in squamous tumours
- Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis
- Spontaneous Squamous Cell Carcinoma Induced by the Somatic Inactivation of <i>Retinoblastoma</i> and <i>Trp53</i> Tumor Suppressors
- Alopecia areata as another immune‐mediated disease developed in patients treated with tumour necrosis factor‐α blocker agents
- Silk‐Inspired In Situ Hydrogel with Anti‐Tumor Immunity Enhanced Photodynamic Therapy for Melanoma and Infected Wound Healing
- Cylindroma as Tumor of Hair Follicle Origin
- The Vitamin D Receptor as Tumor Suppressor in Skin
- Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Cellular plasticity in reprogramming, rejuvenation and tumorigenesis: a pioneer TF perspective
- Homeostasis, regeneration and tumour formation in the mammalian epidermis
- Roles of tumor suppressors in regulating tumor-associated inflammation
- Tumor Mapping in 2 Large Multigenerational Families With CYLD Mutations
- Plasticity of differentiated cells in wound repair and tumorigenesis, part II: skin and intestine
- Tumor suppressor activity of ODC antizyme in MEK-driven skin tumorigenesis
- Meis1 Regulates Epidermal Stem Cells and Is Required for Skin Tumorigenesis
- Tumor Necrosis Factor-Alpha and Polycystic Ovarian Syndrome: A Clinical, Biochemical, and Molecular Genetic Study